Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Operating Expenses | 914 | 872 | 951 | 1,001 | 999 |
Operating Income | -914 | -872 | -951 | -1,001 | -999 |
Other Income | 1 | 1 | 2 | 3 | 6 |
Pre-tax Income | -913 | -871 | -949 | -998 | -993 |
Net Income Continuous | -913 | -871 | -949 | -998 | -993 |
Net Income | $-913 | $-871 | $-949 | $-998 | $-993 |
EPS Basic Total Ops | -52.70 | -59.40 | -67.64 | -67.64 | -67.64 |
EPS Basic Continuous Ops | -55.92 | -59.11 | -64.62 | -67.95 | -67.47 |
EPS Diluted Total Ops | -52.70 | -59.40 | -67.64 | -67.64 | -67.64 |
EPS Diluted Continuous Ops | -55.92 | -59.11 | -64.62 | -67.95 | -67.47 |
EBITDA(a) | $-914 | $-872 | $-951 | $-1,001 | $-999 |